nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—ABCB1—ovarian cancer	0.157	1	CbGaD
Quinidine—SLCO1A2—Chlorambucil—ovarian cancer	0.123	0.211	CbGbCtD
Quinidine—ABCB11—Paclitaxel—ovarian cancer	0.0667	0.114	CbGbCtD
Quinidine—ABCB11—Doxorubicin—ovarian cancer	0.0359	0.0614	CbGbCtD
Quinidine—ABCC2—Paclitaxel—ovarian cancer	0.035	0.0599	CbGbCtD
Quinidine—ABCC2—Carboplatin—ovarian cancer	0.033	0.0564	CbGbCtD
Quinidine—ABCC2—Docetaxel—ovarian cancer	0.0253	0.0433	CbGbCtD
Quinidine—CYP3A7—Paclitaxel—ovarian cancer	0.0234	0.04	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0234	0.04	CbGbCtD
Quinidine—ABCB1—Topotecan—ovarian cancer	0.0231	0.0395	CbGbCtD
Quinidine—ABCC2—Doxorubicin—ovarian cancer	0.0189	0.0323	CbGbCtD
Quinidine—CYP3A7—Docetaxel—ovarian cancer	0.0169	0.0289	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0169	0.0289	CbGbCtD
Quinidine—CYP2C8—Paclitaxel—ovarian cancer	0.0169	0.0289	CbGbCtD
Quinidine—ABCB1—Vinorelbine—ovarian cancer	0.0163	0.0278	CbGbCtD
Quinidine—CYP2D6—Vinorelbine—ovarian cancer	0.0153	0.0262	CbGbCtD
Quinidine—CYP3A4—Topotecan—ovarian cancer	0.0138	0.0236	CbGbCtD
Quinidine—CYP2B6—Doxorubicin—ovarian cancer	0.012	0.0205	CbGbCtD
Quinidine—CYP2C9—Paclitaxel—ovarian cancer	0.0118	0.0201	CbGbCtD
Quinidine—ABCB1—Paclitaxel—ovarian cancer	0.0114	0.0195	CbGbCtD
Quinidine—CYP3A4—Vinorelbine—ovarian cancer	0.00974	0.0167	CbGbCtD
Quinidine—ABCB1—Docetaxel—ovarian cancer	0.00826	0.0141	CbGbCtD
Quinidine—CYP3A4—Paclitaxel—ovarian cancer	0.00685	0.0117	CbGbCtD
Quinidine—ABCB1—Doxorubicin—ovarian cancer	0.00616	0.0105	CbGbCtD
Quinidine—CYP2D6—Doxorubicin—ovarian cancer	0.0058	0.00992	CbGbCtD
Quinidine—CYP3A4—Docetaxel—ovarian cancer	0.00495	0.00846	CbGbCtD
Quinidine—CYP3A4—Doxorubicin—ovarian cancer	0.00369	0.00631	CbGbCtD
Quinidine—KCNK6—gonad—ovarian cancer	0.00317	0.0551	CbGeAlD
Quinidine—KCNK6—female reproductive system—ovarian cancer	0.00283	0.0492	CbGeAlD
Quinidine—KCNK6—testis—ovarian cancer	0.00228	0.0397	CbGeAlD
Quinidine—KCNK1—myometrium—ovarian cancer	0.00215	0.0374	CbGeAlD
Quinidine—KCNK1—uterine cervix—ovarian cancer	0.00167	0.0291	CbGeAlD
Quinidine—KCNK1—decidua—ovarian cancer	0.00159	0.0277	CbGeAlD
Quinidine—KCNK1—endometrium—ovarian cancer	0.00151	0.0263	CbGeAlD
Quinidine—KCNK1—uterus—ovarian cancer	0.0014	0.0242	CbGeAlD
Quinidine—KCNK1—female gonad—ovarian cancer	0.00114	0.0198	CbGeAlD
Quinidine—KCNK1—vagina—ovarian cancer	0.00113	0.0197	CbGeAlD
Quinidine—SLC22A4—myometrium—ovarian cancer	0.00113	0.0196	CbGeAlD
Quinidine—KCNK1—testis—ovarian cancer	0.00101	0.0176	CbGeAlD
Quinidine—SCN3A—decidua—ovarian cancer	0.000955	0.0166	CbGeAlD
Quinidine—ABCB11—testis—ovarian cancer	0.000892	0.0155	CbGeAlD
Quinidine—SLC22A4—decidua—ovarian cancer	0.000836	0.0145	CbGeAlD
Quinidine—ORM1—endometrium—ovarian cancer	0.000825	0.0143	CbGeAlD
Quinidine—SLC22A4—endometrium—ovarian cancer	0.000794	0.0138	CbGeAlD
Quinidine—KCNH2—myometrium—ovarian cancer	0.00079	0.0137	CbGeAlD
Quinidine—SCN2A—vagina—ovarian cancer	0.000773	0.0134	CbGeAlD
Quinidine—SCN3A—female reproductive system—ovarian cancer	0.000751	0.0131	CbGeAlD
Quinidine—SLC22A5—myometrium—ovarian cancer	0.000747	0.013	CbGeAlD
Quinidine—SLCO1B1—female reproductive system—ovarian cancer	0.000741	0.0129	CbGeAlD
Quinidine—KCNK1—lymph node—ovarian cancer	0.000734	0.0128	CbGeAlD
Quinidine—SCN3A—bone marrow—ovarian cancer	0.000709	0.0123	CbGeAlD
Quinidine—ORM1—female reproductive system—ovarian cancer	0.000684	0.0119	CbGeAlD
Quinidine—SCN3A—vagina—ovarian cancer	0.000679	0.0118	CbGeAlD
Quinidine—SCN5A—vagina—ovarian cancer	0.000677	0.0118	CbGeAlD
Quinidine—SLC22A4—female reproductive system—ovarian cancer	0.000658	0.0114	CbGeAlD
Quinidine—ORM1—bone marrow—ovarian cancer	0.000646	0.0112	CbGeAlD
Quinidine—SLC22A4—bone marrow—ovarian cancer	0.000621	0.0108	CbGeAlD
Quinidine—KCNH2—uterine cervix—ovarian cancer	0.000615	0.0107	CbGeAlD
Quinidine—SCN3A—testis—ovarian cancer	0.000606	0.0105	CbGeAlD
Quinidine—SLC22A4—vagina—ovarian cancer	0.000595	0.0103	CbGeAlD
Quinidine—SLC22A5—uterine cervix—ovarian cancer	0.000581	0.0101	CbGeAlD
Quinidine—SLC22A1—vagina—ovarian cancer	0.000566	0.00985	CbGeAlD
Quinidine—ABCC2—female reproductive system—ovarian cancer	0.000562	0.00977	CbGeAlD
Quinidine—KCNH2—endometrium—ovarian cancer	0.000556	0.00966	CbGeAlD
Quinidine—SLC22A5—endometrium—ovarian cancer	0.000525	0.00913	CbGeAlD
Quinidine—CYP1A1—epithelium—ovarian cancer	0.000524	0.0091	CbGeAlD
Quinidine—CYP1A1—uterine cervix—ovarian cancer	0.000519	0.00902	CbGeAlD
Quinidine—KCNH2—uterus—ovarian cancer	0.000512	0.00891	CbGeAlD
Quinidine—CYP2C8—endometrium—ovarian cancer	0.000509	0.00884	CbGeAlD
Quinidine—SLCO1A2—testis—ovarian cancer	0.000487	0.00846	CbGeAlD
Quinidine—KCNH2—female reproductive system—ovarian cancer	0.000461	0.00801	CbGeAlD
Quinidine—ABCC2—testis—ovarian cancer	0.000453	0.00788	CbGeAlD
Quinidine—SCN3A—lymph node—ovarian cancer	0.000439	0.00764	CbGeAlD
Quinidine—SLC22A5—female reproductive system—ovarian cancer	0.000435	0.00757	CbGeAlD
Quinidine—KCNH2—bone marrow—ovarian cancer	0.000435	0.00756	CbGeAlD
Quinidine—CYP1A1—uterus—ovarian cancer	0.000433	0.00752	CbGeAlD
Quinidine—CYP2B6—gonad—ovarian cancer	0.000423	0.00736	CbGeAlD
Quinidine—CYP2C8—female reproductive system—ovarian cancer	0.000421	0.00732	CbGeAlD
Quinidine—KCNH2—female gonad—ovarian cancer	0.000419	0.00728	CbGeAlD
Quinidine—KCNH2—vagina—ovarian cancer	0.000417	0.00724	CbGeAlD
Quinidine—ORM1—lymph node—ovarian cancer	0.0004	0.00695	CbGeAlD
Quinidine—SLC22A5—female gonad—ovarian cancer	0.000396	0.00688	CbGeAlD
Quinidine—SLC22A5—vagina—ovarian cancer	0.000394	0.00684	CbGeAlD
Quinidine—CYP1A1—female reproductive system—ovarian cancer	0.000389	0.00676	CbGeAlD
Quinidine—SLC22A4—lymph node—ovarian cancer	0.000385	0.00669	CbGeAlD
Quinidine—CYP2C8—vagina—ovarian cancer	0.000381	0.00662	CbGeAlD
Quinidine—CYP2B6—female reproductive system—ovarian cancer	0.000378	0.00657	CbGeAlD
Quinidine—CYP2C9—female reproductive system—ovarian cancer	0.000374	0.00651	CbGeAlD
Quinidine—KCNH2—testis—ovarian cancer	0.000372	0.00646	CbGeAlD
Quinidine—CYP2E1—female reproductive system—ovarian cancer	0.000355	0.00617	CbGeAlD
Quinidine—CYP1A1—female gonad—ovarian cancer	0.000354	0.00615	CbGeAlD
Quinidine—CYP1A1—vagina—ovarian cancer	0.000352	0.00611	CbGeAlD
Quinidine—SLC22A5—testis—ovarian cancer	0.000351	0.00611	CbGeAlD
Quinidine—ABCB1—myometrium—ovarian cancer	0.000347	0.00602	CbGeAlD
Quinidine—CYP2B6—vagina—ovarian cancer	0.000342	0.00594	CbGeAlD
Quinidine—CYP2C8—testis—ovarian cancer	0.00034	0.00591	CbGeAlD
Quinidine—ABCB1—embryo—ovarian cancer	0.000333	0.00579	CbGeAlD
Quinidine—ABCC2—lymph node—ovarian cancer	0.000329	0.00571	CbGeAlD
Quinidine—CYP2B6—testis—ovarian cancer	0.000305	0.0053	CbGeAlD
Quinidine—CYP2E1—testis—ovarian cancer	0.000286	0.00498	CbGeAlD
Quinidine—CYP3A4—female reproductive system—ovarian cancer	0.000285	0.00496	CbGeAlD
Quinidine—CYP2D6—female reproductive system—ovarian cancer	0.000281	0.00488	CbGeAlD
Quinidine—ABCB1—epithelium—ovarian cancer	0.000272	0.00473	CbGeAlD
Quinidine—ABCB1—uterine cervix—ovarian cancer	0.00027	0.00469	CbGeAlD
Quinidine—KCNH2—lymph node—ovarian cancer	0.000269	0.00468	CbGeAlD
Quinidine—ABCB1—decidua—ovarian cancer	0.000257	0.00447	CbGeAlD
Quinidine—CYP2D6—female gonad—ovarian cancer	0.000256	0.00444	CbGeAlD
Quinidine—SLC22A5—lymph node—ovarian cancer	0.000255	0.00443	CbGeAlD
Quinidine—ABCB1—endometrium—ovarian cancer	0.000244	0.00424	CbGeAlD
Quinidine—CYP1A1—lymph node—ovarian cancer	0.000228	0.00396	CbGeAlD
Quinidine—CYP2D6—testis—ovarian cancer	0.000227	0.00394	CbGeAlD
Quinidine—ABCB1—gonad—ovarian cancer	0.000226	0.00393	CbGeAlD
Quinidine—ABCB1—uterus—ovarian cancer	0.000225	0.00391	CbGeAlD
Quinidine—ABCB1—female reproductive system—ovarian cancer	0.000202	0.00351	CbGeAlD
Quinidine—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000199	0.00119	CcSEcCtD
Quinidine—Vertigo—Paclitaxel—ovarian cancer	0.000199	0.00119	CcSEcCtD
Quinidine—Syncope—Paclitaxel—ovarian cancer	0.000199	0.00119	CcSEcCtD
Quinidine—Leukopenia—Paclitaxel—ovarian cancer	0.000198	0.00119	CcSEcCtD
Quinidine—Rash—Topotecan—ovarian cancer	0.000198	0.00119	CcSEcCtD
Quinidine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000198	0.00119	CcSEcCtD
Quinidine—Dermatitis—Topotecan—ovarian cancer	0.000198	0.00118	CcSEcCtD
Quinidine—Ataxia—Epirubicin—ovarian cancer	0.000198	0.00118	CcSEcCtD
Quinidine—Headache—Topotecan—ovarian cancer	0.000197	0.00118	CcSEcCtD
Quinidine—Palpitations—Paclitaxel—ovarian cancer	0.000196	0.00117	CcSEcCtD
Quinidine—Vomiting—Melphalan—ovarian cancer	0.000196	0.00117	CcSEcCtD
Quinidine—Immune system disorder—Docetaxel—ovarian cancer	0.000195	0.00117	CcSEcCtD
Quinidine—Loss of consciousness—Paclitaxel—ovarian cancer	0.000195	0.00117	CcSEcCtD
Quinidine—Diplopia—Doxorubicin—ovarian cancer	0.000195	0.00116	CcSEcCtD
Quinidine—Mediastinal disorder—Docetaxel—ovarian cancer	0.000194	0.00116	CcSEcCtD
Quinidine—Liver function test abnormal—Epirubicin—ovarian cancer	0.000194	0.00116	CcSEcCtD
Quinidine—Rash—Melphalan—ovarian cancer	0.000194	0.00116	CcSEcCtD
Quinidine—Dermatitis—Melphalan—ovarian cancer	0.000194	0.00116	CcSEcCtD
Quinidine—Chills—Docetaxel—ovarian cancer	0.000194	0.00116	CcSEcCtD
Quinidine—Asthenia—Vinorelbine—ovarian cancer	0.000193	0.00115	CcSEcCtD
Quinidine—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000192	0.00115	CcSEcCtD
Quinidine—Abdominal pain upper—Epirubicin—ovarian cancer	0.000192	0.00115	CcSEcCtD
Quinidine—Convulsion—Paclitaxel—ovarian cancer	0.000192	0.00115	CcSEcCtD
Quinidine—ABCB1—bone marrow—ovarian cancer	0.000191	0.00332	CbGeAlD
Quinidine—Pruritus—Vinorelbine—ovarian cancer	0.00019	0.00114	CcSEcCtD
Quinidine—Breast disorder—Epirubicin—ovarian cancer	0.00019	0.00114	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000189	0.00113	CcSEcCtD
Quinidine—Mental disorder—Docetaxel—ovarian cancer	0.000189	0.00113	CcSEcCtD
Quinidine—Myalgia—Paclitaxel—ovarian cancer	0.000189	0.00113	CcSEcCtD
Quinidine—Chest pain—Paclitaxel—ovarian cancer	0.000189	0.00113	CcSEcCtD
Quinidine—Malnutrition—Docetaxel—ovarian cancer	0.000188	0.00112	CcSEcCtD
Quinidine—Erythema—Docetaxel—ovarian cancer	0.000188	0.00112	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000187	0.00112	CcSEcCtD
Quinidine—Nausea—Topotecan—ovarian cancer	0.000187	0.00112	CcSEcCtD
Quinidine—Muscular weakness—Epirubicin—ovarian cancer	0.000186	0.00111	CcSEcCtD
Quinidine—Cardiac arrest—Doxorubicin—ovarian cancer	0.000185	0.00111	CcSEcCtD
Quinidine—Diarrhoea—Vinorelbine—ovarian cancer	0.000184	0.0011	CcSEcCtD
Quinidine—ABCB1—female gonad—ovarian cancer	0.000184	0.0032	CbGeAlD
Quinidine—Ataxia—Doxorubicin—ovarian cancer	0.000183	0.0011	CcSEcCtD
Quinidine—Nausea—Melphalan—ovarian cancer	0.000183	0.00109	CcSEcCtD
Quinidine—ABCB1—vagina—ovarian cancer	0.000183	0.00318	CbGeAlD
Quinidine—Confusional state—Paclitaxel—ovarian cancer	0.000182	0.00109	CcSEcCtD
Quinidine—Asthma—Epirubicin—ovarian cancer	0.000182	0.00109	CcSEcCtD
Quinidine—Oedema—Paclitaxel—ovarian cancer	0.000181	0.00108	CcSEcCtD
Quinidine—Liver function test abnormal—Doxorubicin—ovarian cancer	0.00018	0.00108	CcSEcCtD
Quinidine—Shock—Paclitaxel—ovarian cancer	0.000178	0.00106	CcSEcCtD
Quinidine—Dizziness—Vinorelbine—ovarian cancer	0.000178	0.00106	CcSEcCtD
Quinidine—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000178	0.00106	CcSEcCtD
Quinidine—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000178	0.00106	CcSEcCtD
Quinidine—Nervous system disorder—Paclitaxel—ovarian cancer	0.000177	0.00106	CcSEcCtD
Quinidine—Angina pectoris—Epirubicin—ovarian cancer	0.000177	0.00106	CcSEcCtD
Quinidine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000177	0.00106	CcSEcCtD
Quinidine—Tachycardia—Paclitaxel—ovarian cancer	0.000177	0.00106	CcSEcCtD
Quinidine—Breast disorder—Doxorubicin—ovarian cancer	0.000176	0.00105	CcSEcCtD
Quinidine—Skin disorder—Paclitaxel—ovarian cancer	0.000176	0.00105	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000175	0.00105	CcSEcCtD
Quinidine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000175	0.00105	CcSEcCtD
Quinidine—Pancytopenia—Epirubicin—ovarian cancer	0.000173	0.00103	CcSEcCtD
Quinidine—Anorexia—Paclitaxel—ovarian cancer	0.000172	0.00103	CcSEcCtD
Quinidine—Muscular weakness—Doxorubicin—ovarian cancer	0.000172	0.00103	CcSEcCtD
Quinidine—Vomiting—Vinorelbine—ovarian cancer	0.000171	0.00102	CcSEcCtD
Quinidine—Neutropenia—Epirubicin—ovarian cancer	0.00017	0.00102	CcSEcCtD
Quinidine—Rash—Vinorelbine—ovarian cancer	0.00017	0.00101	CcSEcCtD
Quinidine—Dermatitis—Vinorelbine—ovarian cancer	0.000169	0.00101	CcSEcCtD
Quinidine—Hypotension—Paclitaxel—ovarian cancer	0.000169	0.00101	CcSEcCtD
Quinidine—Headache—Vinorelbine—ovarian cancer	0.000168	0.00101	CcSEcCtD
Quinidine—Syncope—Docetaxel—ovarian cancer	0.000168	0.00101	CcSEcCtD
Quinidine—Asthma—Doxorubicin—ovarian cancer	0.000168	0.00101	CcSEcCtD
Quinidine—Leukopenia—Docetaxel—ovarian cancer	0.000168	0.00101	CcSEcCtD
Quinidine—Palpitations—Docetaxel—ovarian cancer	0.000166	0.000993	CcSEcCtD
Quinidine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000166	0.000993	CcSEcCtD
Quinidine—Loss of consciousness—Docetaxel—ovarian cancer	0.000165	0.000988	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000165	0.000986	CcSEcCtD
Quinidine—Angina pectoris—Doxorubicin—ovarian cancer	0.000164	0.00098	CcSEcCtD
Quinidine—ABCB1—testis—ovarian cancer	0.000163	0.00283	CbGeAlD
Quinidine—Convulsion—Docetaxel—ovarian cancer	0.000163	0.000974	CcSEcCtD
Quinidine—Dyspnoea—Paclitaxel—ovarian cancer	0.000161	0.000965	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000161	0.000962	CcSEcCtD
Quinidine—Chest pain—Docetaxel—ovarian cancer	0.00016	0.000957	CcSEcCtD
Quinidine—Myalgia—Docetaxel—ovarian cancer	0.00016	0.000957	CcSEcCtD
Quinidine—Pancytopenia—Doxorubicin—ovarian cancer	0.00016	0.000956	CcSEcCtD
Quinidine—Nausea—Vinorelbine—ovarian cancer	0.00016	0.000956	CcSEcCtD
Quinidine—Renal failure—Epirubicin—ovarian cancer	0.000159	0.000953	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000159	0.00095	CcSEcCtD
Quinidine—Jaundice—Epirubicin—ovarian cancer	0.000158	0.000945	CcSEcCtD
Quinidine—Neutropenia—Doxorubicin—ovarian cancer	0.000157	0.000941	CcSEcCtD
Quinidine—Decreased appetite—Paclitaxel—ovarian cancer	0.000157	0.000941	CcSEcCtD
Quinidine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000156	0.000934	CcSEcCtD
Quinidine—Sweating—Epirubicin—ovarian cancer	0.000155	0.00093	CcSEcCtD
Quinidine—Confusional state—Docetaxel—ovarian cancer	0.000155	0.000925	CcSEcCtD
Quinidine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000154	0.000919	CcSEcCtD
Quinidine—Oedema—Docetaxel—ovarian cancer	0.000153	0.000917	CcSEcCtD
Quinidine—Agranulocytosis—Epirubicin—ovarian cancer	0.000151	0.000905	CcSEcCtD
Quinidine—Shock—Docetaxel—ovarian cancer	0.000151	0.000902	CcSEcCtD
Quinidine—Nervous system disorder—Docetaxel—ovarian cancer	0.00015	0.000899	CcSEcCtD
Quinidine—Thrombocytopenia—Docetaxel—ovarian cancer	0.00015	0.000898	CcSEcCtD
Quinidine—Tachycardia—Docetaxel—ovarian cancer	0.00015	0.000895	CcSEcCtD
Quinidine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000149	0.000892	CcSEcCtD
Quinidine—Skin disorder—Docetaxel—ovarian cancer	0.000149	0.000891	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000149	0.00089	CcSEcCtD
Quinidine—Bradycardia—Epirubicin—ovarian cancer	0.000148	0.000886	CcSEcCtD
Quinidine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000148	0.000885	CcSEcCtD
Quinidine—Renal failure—Doxorubicin—ovarian cancer	0.000147	0.000882	CcSEcCtD
Quinidine—Haemoglobin—Epirubicin—ovarian cancer	0.000146	0.000875	CcSEcCtD
Quinidine—Jaundice—Doxorubicin—ovarian cancer	0.000146	0.000875	CcSEcCtD
Quinidine—Anorexia—Docetaxel—ovarian cancer	0.000146	0.000874	CcSEcCtD
Quinidine—Haemorrhage—Epirubicin—ovarian cancer	0.000146	0.000871	CcSEcCtD
Quinidine—Hepatitis—Epirubicin—ovarian cancer	0.000146	0.000871	CcSEcCtD
Quinidine—Sweating—Doxorubicin—ovarian cancer	0.000144	0.00086	CcSEcCtD
Quinidine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000144	0.00086	CcSEcCtD
Quinidine—Urticaria—Paclitaxel—ovarian cancer	0.000144	0.00086	CcSEcCtD
Quinidine—Hypotension—Docetaxel—ovarian cancer	0.000143	0.000857	CcSEcCtD
Quinidine—Abdominal pain—Paclitaxel—ovarian cancer	0.000143	0.000855	CcSEcCtD
Quinidine—Body temperature increased—Paclitaxel—ovarian cancer	0.000143	0.000855	CcSEcCtD
Quinidine—Urethral disorder—Epirubicin—ovarian cancer	0.000143	0.000853	CcSEcCtD
Quinidine—Visual impairment—Epirubicin—ovarian cancer	0.00014	0.000839	CcSEcCtD
Quinidine—Agranulocytosis—Doxorubicin—ovarian cancer	0.00014	0.000837	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00014	0.000836	CcSEcCtD
Quinidine—Erythema multiforme—Epirubicin—ovarian cancer	0.000138	0.000823	CcSEcCtD
Quinidine—Bradycardia—Doxorubicin—ovarian cancer	0.000137	0.00082	CcSEcCtD
Quinidine—Dyspnoea—Docetaxel—ovarian cancer	0.000137	0.000818	CcSEcCtD
Quinidine—Eye disorder—Epirubicin—ovarian cancer	0.000136	0.000814	CcSEcCtD
Quinidine—Tinnitus—Epirubicin—ovarian cancer	0.000136	0.000812	CcSEcCtD
Quinidine—Haemoglobin—Doxorubicin—ovarian cancer	0.000135	0.00081	CcSEcCtD
Quinidine—Flushing—Epirubicin—ovarian cancer	0.000135	0.000808	CcSEcCtD
Quinidine—Cardiac disorder—Epirubicin—ovarian cancer	0.000135	0.000808	CcSEcCtD
Quinidine—Haemorrhage—Doxorubicin—ovarian cancer	0.000135	0.000806	CcSEcCtD
Quinidine—Hepatitis—Doxorubicin—ovarian cancer	0.000135	0.000806	CcSEcCtD
Quinidine—Decreased appetite—Docetaxel—ovarian cancer	0.000133	0.000797	CcSEcCtD
Quinidine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000133	0.000797	CcSEcCtD
Quinidine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000133	0.000796	CcSEcCtD
Quinidine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000132	0.000792	CcSEcCtD
Quinidine—Urethral disorder—Doxorubicin—ovarian cancer	0.000132	0.00079	CcSEcCtD
Quinidine—Immune system disorder—Epirubicin—ovarian cancer	0.000131	0.000786	CcSEcCtD
Quinidine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000131	0.000785	CcSEcCtD
Quinidine—Chills—Epirubicin—ovarian cancer	0.000131	0.000781	CcSEcCtD
Quinidine—Visual impairment—Doxorubicin—ovarian cancer	0.00013	0.000776	CcSEcCtD
Quinidine—Asthenia—Paclitaxel—ovarian cancer	0.00013	0.000776	CcSEcCtD
Quinidine—Pruritus—Paclitaxel—ovarian cancer	0.000128	0.000766	CcSEcCtD
Quinidine—Mental disorder—Epirubicin—ovarian cancer	0.000128	0.000763	CcSEcCtD
Quinidine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000127	0.000762	CcSEcCtD
Quinidine—Malnutrition—Epirubicin—ovarian cancer	0.000127	0.000758	CcSEcCtD
Quinidine—Erythema—Epirubicin—ovarian cancer	0.000127	0.000758	CcSEcCtD
Quinidine—Feeling abnormal—Docetaxel—ovarian cancer	0.000126	0.000756	CcSEcCtD
Quinidine—Eye disorder—Doxorubicin—ovarian cancer	0.000126	0.000753	CcSEcCtD
Quinidine—Tinnitus—Doxorubicin—ovarian cancer	0.000126	0.000751	CcSEcCtD
Quinidine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000125	0.00075	CcSEcCtD
Quinidine—Flushing—Doxorubicin—ovarian cancer	0.000125	0.000748	CcSEcCtD
Quinidine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000125	0.000748	CcSEcCtD
Quinidine—Diarrhoea—Paclitaxel—ovarian cancer	0.000124	0.00074	CcSEcCtD
Quinidine—Immune system disorder—Doxorubicin—ovarian cancer	0.000122	0.000728	CcSEcCtD
Quinidine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000121	0.000726	CcSEcCtD
Quinidine—Body temperature increased—Docetaxel—ovarian cancer	0.000121	0.000725	CcSEcCtD
Quinidine—Abdominal pain—Docetaxel—ovarian cancer	0.000121	0.000725	CcSEcCtD
Quinidine—Chills—Doxorubicin—ovarian cancer	0.000121	0.000723	CcSEcCtD
Quinidine—Dizziness—Paclitaxel—ovarian cancer	0.00012	0.000715	CcSEcCtD
Quinidine—Vision blurred—Epirubicin—ovarian cancer	0.000119	0.000714	CcSEcCtD
Quinidine—ABCB1—lymph node—ovarian cancer	0.000118	0.00205	CbGeAlD
Quinidine—Mental disorder—Doxorubicin—ovarian cancer	0.000118	0.000706	CcSEcCtD
Quinidine—Malnutrition—Doxorubicin—ovarian cancer	0.000117	0.000701	CcSEcCtD
Quinidine—Erythema—Doxorubicin—ovarian cancer	0.000117	0.000701	CcSEcCtD
Quinidine—Agitation—Epirubicin—ovarian cancer	0.000116	0.000697	CcSEcCtD
Quinidine—Vomiting—Paclitaxel—ovarian cancer	0.000115	0.000688	CcSEcCtD
Quinidine—Rash—Paclitaxel—ovarian cancer	0.000114	0.000682	CcSEcCtD
Quinidine—Dermatitis—Paclitaxel—ovarian cancer	0.000114	0.000682	CcSEcCtD
Quinidine—Vertigo—Epirubicin—ovarian cancer	0.000114	0.000681	CcSEcCtD
Quinidine—Syncope—Epirubicin—ovarian cancer	0.000114	0.00068	CcSEcCtD
Quinidine—Leukopenia—Epirubicin—ovarian cancer	0.000113	0.000678	CcSEcCtD
Quinidine—Headache—Paclitaxel—ovarian cancer	0.000113	0.000678	CcSEcCtD
Quinidine—Hypersensitivity—Docetaxel—ovarian cancer	0.000113	0.000676	CcSEcCtD
Quinidine—Palpitations—Epirubicin—ovarian cancer	0.000112	0.00067	CcSEcCtD
Quinidine—Loss of consciousness—Epirubicin—ovarian cancer	0.000111	0.000666	CcSEcCtD
Quinidine—Vision blurred—Doxorubicin—ovarian cancer	0.00011	0.000661	CcSEcCtD
Quinidine—Asthenia—Docetaxel—ovarian cancer	0.00011	0.000658	CcSEcCtD
Quinidine—Convulsion—Epirubicin—ovarian cancer	0.00011	0.000657	CcSEcCtD
Quinidine—Pruritus—Docetaxel—ovarian cancer	0.000108	0.000649	CcSEcCtD
Quinidine—Chest pain—Epirubicin—ovarian cancer	0.000108	0.000645	CcSEcCtD
Quinidine—Myalgia—Epirubicin—ovarian cancer	0.000108	0.000645	CcSEcCtD
Quinidine—Agitation—Doxorubicin—ovarian cancer	0.000108	0.000644	CcSEcCtD
Quinidine—Nausea—Paclitaxel—ovarian cancer	0.000107	0.000643	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000107	0.000641	CcSEcCtD
Quinidine—Vertigo—Doxorubicin—ovarian cancer	0.000105	0.00063	CcSEcCtD
Quinidine—Syncope—Doxorubicin—ovarian cancer	0.000105	0.000629	CcSEcCtD
Quinidine—Leukopenia—Doxorubicin—ovarian cancer	0.000105	0.000628	CcSEcCtD
Quinidine—Diarrhoea—Docetaxel—ovarian cancer	0.000105	0.000627	CcSEcCtD
Quinidine—Confusional state—Epirubicin—ovarian cancer	0.000104	0.000624	CcSEcCtD
Quinidine—Palpitations—Doxorubicin—ovarian cancer	0.000104	0.00062	CcSEcCtD
Quinidine—Oedema—Epirubicin—ovarian cancer	0.000103	0.000619	CcSEcCtD
Quinidine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000103	0.000616	CcSEcCtD
Quinidine—Shock—Epirubicin—ovarian cancer	0.000102	0.000609	CcSEcCtD
Quinidine—Convulsion—Doxorubicin—ovarian cancer	0.000102	0.000608	CcSEcCtD
Quinidine—Nervous system disorder—Epirubicin—ovarian cancer	0.000101	0.000607	CcSEcCtD
Quinidine—Dizziness—Docetaxel—ovarian cancer	0.000101	0.000606	CcSEcCtD
Quinidine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000101	0.000606	CcSEcCtD
Quinidine—Tachycardia—Epirubicin—ovarian cancer	0.000101	0.000604	CcSEcCtD
Quinidine—Skin disorder—Epirubicin—ovarian cancer	0.0001	0.000601	CcSEcCtD
Quinidine—Hyperhidrosis—Epirubicin—ovarian cancer	0.0001	0.000598	CcSEcCtD
Quinidine—Chest pain—Doxorubicin—ovarian cancer	9.98e-05	0.000597	CcSEcCtD
Quinidine—Myalgia—Doxorubicin—ovarian cancer	9.98e-05	0.000597	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	9.91e-05	0.000593	CcSEcCtD
Quinidine—Anorexia—Epirubicin—ovarian cancer	9.86e-05	0.00059	CcSEcCtD
Quinidine—Vomiting—Docetaxel—ovarian cancer	9.75e-05	0.000583	CcSEcCtD
Quinidine—Rash—Docetaxel—ovarian cancer	9.67e-05	0.000578	CcSEcCtD
Quinidine—Hypotension—Epirubicin—ovarian cancer	9.66e-05	0.000578	CcSEcCtD
Quinidine—Dermatitis—Docetaxel—ovarian cancer	9.66e-05	0.000578	CcSEcCtD
Quinidine—Confusional state—Doxorubicin—ovarian cancer	9.65e-05	0.000577	CcSEcCtD
Quinidine—Headache—Docetaxel—ovarian cancer	9.6e-05	0.000575	CcSEcCtD
Quinidine—Oedema—Doxorubicin—ovarian cancer	9.57e-05	0.000572	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	9.42e-05	0.000564	CcSEcCtD
Quinidine—Shock—Doxorubicin—ovarian cancer	9.41e-05	0.000563	CcSEcCtD
Quinidine—Nervous system disorder—Doxorubicin—ovarian cancer	9.38e-05	0.000561	CcSEcCtD
Quinidine—Thrombocytopenia—Doxorubicin—ovarian cancer	9.37e-05	0.00056	CcSEcCtD
Quinidine—Tachycardia—Doxorubicin—ovarian cancer	9.34e-05	0.000559	CcSEcCtD
Quinidine—Skin disorder—Doxorubicin—ovarian cancer	9.29e-05	0.000556	CcSEcCtD
Quinidine—Hyperhidrosis—Doxorubicin—ovarian cancer	9.25e-05	0.000553	CcSEcCtD
Quinidine—Dyspnoea—Epirubicin—ovarian cancer	9.22e-05	0.000551	CcSEcCtD
Quinidine—Anorexia—Doxorubicin—ovarian cancer	9.12e-05	0.000546	CcSEcCtD
Quinidine—Nausea—Docetaxel—ovarian cancer	9.11e-05	0.000545	CcSEcCtD
Quinidine—Decreased appetite—Epirubicin—ovarian cancer	8.99e-05	0.000538	CcSEcCtD
Quinidine—Hypotension—Doxorubicin—ovarian cancer	8.94e-05	0.000535	CcSEcCtD
Quinidine—Gastrointestinal disorder—Epirubicin—ovarian cancer	8.93e-05	0.000534	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	8.72e-05	0.000521	CcSEcCtD
Quinidine—Dyspnoea—Doxorubicin—ovarian cancer	8.53e-05	0.00051	CcSEcCtD
Quinidine—Feeling abnormal—Epirubicin—ovarian cancer	8.52e-05	0.00051	CcSEcCtD
Quinidine—Gastrointestinal pain—Epirubicin—ovarian cancer	8.46e-05	0.000506	CcSEcCtD
Quinidine—Decreased appetite—Doxorubicin—ovarian cancer	8.32e-05	0.000498	CcSEcCtD
Quinidine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	8.26e-05	0.000494	CcSEcCtD
Quinidine—Urticaria—Epirubicin—ovarian cancer	8.21e-05	0.000491	CcSEcCtD
Quinidine—Abdominal pain—Epirubicin—ovarian cancer	8.17e-05	0.000489	CcSEcCtD
Quinidine—Body temperature increased—Epirubicin—ovarian cancer	8.17e-05	0.000489	CcSEcCtD
Quinidine—Feeling abnormal—Doxorubicin—ovarian cancer	7.88e-05	0.000472	CcSEcCtD
Quinidine—Quinine—ABCB1—ovarian cancer	7.85e-05	1	CrCbGaD
Quinidine—Gastrointestinal pain—Doxorubicin—ovarian cancer	7.82e-05	0.000468	CcSEcCtD
Quinidine—Hypersensitivity—Epirubicin—ovarian cancer	7.62e-05	0.000456	CcSEcCtD
Quinidine—Urticaria—Doxorubicin—ovarian cancer	7.6e-05	0.000455	CcSEcCtD
Quinidine—Abdominal pain—Doxorubicin—ovarian cancer	7.56e-05	0.000452	CcSEcCtD
Quinidine—Body temperature increased—Doxorubicin—ovarian cancer	7.56e-05	0.000452	CcSEcCtD
Quinidine—Asthenia—Epirubicin—ovarian cancer	7.42e-05	0.000444	CcSEcCtD
Quinidine—Pruritus—Epirubicin—ovarian cancer	7.32e-05	0.000438	CcSEcCtD
Quinidine—Diarrhoea—Epirubicin—ovarian cancer	7.07e-05	0.000423	CcSEcCtD
Quinidine—Hypersensitivity—Doxorubicin—ovarian cancer	7.05e-05	0.000422	CcSEcCtD
Quinidine—Asthenia—Doxorubicin—ovarian cancer	6.86e-05	0.000411	CcSEcCtD
Quinidine—Dizziness—Epirubicin—ovarian cancer	6.84e-05	0.000409	CcSEcCtD
Quinidine—Pruritus—Doxorubicin—ovarian cancer	6.77e-05	0.000405	CcSEcCtD
Quinidine—Vomiting—Epirubicin—ovarian cancer	6.57e-05	0.000393	CcSEcCtD
Quinidine—Diarrhoea—Doxorubicin—ovarian cancer	6.55e-05	0.000392	CcSEcCtD
Quinidine—Rash—Epirubicin—ovarian cancer	6.52e-05	0.00039	CcSEcCtD
Quinidine—Dermatitis—Epirubicin—ovarian cancer	6.51e-05	0.00039	CcSEcCtD
Quinidine—Headache—Epirubicin—ovarian cancer	6.48e-05	0.000388	CcSEcCtD
Quinidine—Dizziness—Doxorubicin—ovarian cancer	6.33e-05	0.000378	CcSEcCtD
Quinidine—Nausea—Epirubicin—ovarian cancer	6.14e-05	0.000367	CcSEcCtD
Quinidine—Vomiting—Doxorubicin—ovarian cancer	6.08e-05	0.000364	CcSEcCtD
Quinidine—Rash—Doxorubicin—ovarian cancer	6.03e-05	0.000361	CcSEcCtD
Quinidine—Dermatitis—Doxorubicin—ovarian cancer	6.03e-05	0.000361	CcSEcCtD
Quinidine—Headache—Doxorubicin—ovarian cancer	5.99e-05	0.000359	CcSEcCtD
Quinidine—Nausea—Doxorubicin—ovarian cancer	5.68e-05	0.00034	CcSEcCtD
Quinidine—ABCB11—Metabolism—PIK3CD—ovarian cancer	7.21e-06	0.000215	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—FASN—ovarian cancer	7.2e-06	0.000215	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.18e-06	0.000214	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—PIK3CG—ovarian cancer	7.13e-06	0.000213	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	7.13e-06	0.000213	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—SLC5A5—ovarian cancer	7.08e-06	0.000211	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PARP1—ovarian cancer	7.05e-06	0.00021	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYTB—ovarian cancer	6.99e-06	0.000209	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—SLC2A1—ovarian cancer	6.99e-06	0.000209	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—ABCB1—ovarian cancer	6.94e-06	0.000207	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PIK3CG—ovarian cancer	6.85e-06	0.000204	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—SLC2A1—ovarian cancer	6.84e-06	0.000204	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—TYMS—ovarian cancer	6.82e-06	0.000203	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—FASN—ovarian cancer	6.79e-06	0.000203	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.75e-06	0.000202	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—IL6ST—ovarian cancer	6.74e-06	0.000201	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CYP1B1—ovarian cancer	6.7e-06	0.0002	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—SLC5A5—ovarian cancer	6.68e-06	0.000199	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—YAP1—ovarian cancer	6.65e-06	0.000199	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.64e-06	0.000198	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CYP1B1—ovarian cancer	6.56e-06	0.000196	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—PIK3CG—ovarian cancer	6.48e-06	0.000193	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—SLC2A1—ovarian cancer	6.45e-06	0.000193	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—CAV1—ovarian cancer	6.43e-06	0.000192	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.32e-06	0.000189	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PIK3CB—ovarian cancer	6.29e-06	0.000188	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—PIK3CD—ovarian cancer	6.27e-06	0.000187	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—YAP1—ovarian cancer	6.27e-06	0.000187	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—FASN—ovarian cancer	6.23e-06	0.000186	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—YAP1—ovarian cancer	6.22e-06	0.000186	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CYP1B1—ovarian cancer	6.18e-06	0.000185	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.15e-06	0.000184	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.14e-06	0.000183	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—SLC5A5—ovarian cancer	6.12e-06	0.000183	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	6.11e-06	0.000182	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—BRIP1—ovarian cancer	6.11e-06	0.000182	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	6.02e-06	0.00018	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	6.02e-06	0.00018	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	5.94e-06	0.000177	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—SLC2A1—ovarian cancer	5.91e-06	0.000177	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—CAV1—ovarian cancer	5.9e-06	0.000176	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—CAV1—ovarian cancer	5.89e-06	0.000176	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	5.86e-06	0.000175	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	5.82e-06	0.000174	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.79e-06	0.000173	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.77e-06	0.000172	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PPP2R1A—ovarian cancer	5.72e-06	0.000171	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—PIK3CD—ovarian cancer	5.69e-06	0.00017	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CYP1B1—ovarian cancer	5.67e-06	0.000169	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—ABCB1—ovarian cancer	5.52e-06	0.000165	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—CAV1—ovarian cancer	5.49e-06	0.000164	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	5.49e-06	0.000164	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—PIK3CB—ovarian cancer	5.47e-06	0.000163	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.46e-06	0.000163	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PTEN—ovarian cancer	5.43e-06	0.000162	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—FASN—ovarian cancer	5.42e-06	0.000162	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—TYMS—ovarian cancer	5.42e-06	0.000162	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.41e-06	0.000161	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—ABCB1—ovarian cancer	5.4e-06	0.000161	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PIK3CG—ovarian cancer	5.38e-06	0.00016	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PIK3CG—ovarian cancer	5.37e-06	0.00016	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—SLC5A5—ovarian cancer	5.34e-06	0.000159	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—YAP1—ovarian cancer	5.31e-06	0.000159	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—TYMS—ovarian cancer	5.31e-06	0.000158	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.26e-06	0.000157	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—CXCL8—ovarian cancer	5.25e-06	0.000157	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	5.25e-06	0.000157	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—SLC2A1—ovarian cancer	5.15e-06	0.000154	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	5.15e-06	0.000154	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—FASN—ovarian cancer	5.11e-06	0.000153	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—ABCB1—ovarian cancer	5.09e-06	0.000152	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—FASN—ovarian cancer	5.07e-06	0.000151	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	5.03e-06	0.00015	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—SLC5A5—ovarian cancer	5.03e-06	0.00015	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—IL2—ovarian cancer	5.02e-06	0.00015	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5e-06	0.000149	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CG—ovarian cancer	5e-06	0.000149	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—TYMS—ovarian cancer	5e-06	0.000149	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—SLC5A5—ovarian cancer	4.98e-06	0.000149	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—PIK3CB—ovarian cancer	4.96e-06	0.000148	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CYP1B1—ovarian cancer	4.94e-06	0.000147	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—SLC2A1—ovarian cancer	4.86e-06	0.000145	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—SLC2A1—ovarian cancer	4.81e-06	0.000144	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CXCL8—ovarian cancer	4.77e-06	0.000142	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PIK3CD—ovarian cancer	4.73e-06	0.000141	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PIK3CD—ovarian cancer	4.72e-06	0.000141	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.71e-06	0.000141	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—ABCB1—ovarian cancer	4.67e-06	0.000139	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	4.66e-06	0.000139	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.62e-06	0.000138	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CYP1B1—ovarian cancer	4.61e-06	0.000138	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—TYMS—ovarian cancer	4.59e-06	0.000137	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—IL2—ovarian cancer	4.56e-06	0.000136	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TERT—ovarian cancer	4.54e-06	0.000136	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PTEN—ovarian cancer	4.54e-06	0.000135	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	4.49e-06	0.000134	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CD—ovarian cancer	4.4e-06	0.000131	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PPP2R1A—ovarian cancer	4.38e-06	0.000131	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CAV1—ovarian cancer	4.36e-06	0.00013	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—FASN—ovarian cancer	4.33e-06	0.000129	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CAV1—ovarian cancer	4.28e-06	0.000128	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—SLC5A5—ovarian cancer	4.26e-06	0.000127	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CAV1—ovarian cancer	4.2e-06	0.000125	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	4.13e-06	0.000123	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PIK3CB—ovarian cancer	4.12e-06	0.000123	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—SLC2A1—ovarian cancer	4.11e-06	0.000123	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PIK3CB—ovarian cancer	4.11e-06	0.000123	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—YAP1—ovarian cancer	4.1e-06	0.000122	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	4.09e-06	0.000122	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.07e-06	0.000122	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—ESR1—ovarian cancer	4.05e-06	0.000121	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CAV1—ovarian cancer	4.03e-06	0.00012	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.03e-06	0.00012	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—TYMS—ovarian cancer	4e-06	0.000119	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL6ST—ovarian cancer	3.98e-06	0.000119	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CG—ovarian cancer	3.98e-06	0.000119	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CYP1B1—ovarian cancer	3.94e-06	0.000118	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CG—ovarian cancer	3.89e-06	0.000116	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PTEN—ovarian cancer	3.88e-06	0.000116	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.85e-06	0.000115	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CB—ovarian cancer	3.83e-06	0.000114	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—ABCB1—ovarian cancer	3.83e-06	0.000114	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PIK3CA—ovarian cancer	3.83e-06	0.000114	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—APC—ovarian cancer	3.83e-06	0.000114	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CG—ovarian cancer	3.83e-06	0.000114	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—NRAS—ovarian cancer	3.83e-06	0.000114	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—ABCB1—ovarian cancer	3.8e-06	0.000113	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—TYMS—ovarian cancer	3.76e-06	0.000112	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—TYMS—ovarian cancer	3.73e-06	0.000111	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CAV1—ovarian cancer	3.7e-06	0.00011	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CG—ovarian cancer	3.67e-06	0.00011	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—MAPK3—ovarian cancer	3.67e-06	0.000109	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PTEN—ovarian cancer	3.56e-06	0.000106	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PTEN—ovarian cancer	3.55e-06	0.000106	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.53e-06	0.000105	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	3.5e-06	0.000104	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CD—ovarian cancer	3.5e-06	0.000104	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—MAPK1—ovarian cancer	3.49e-06	0.000104	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—EGFR—ovarian cancer	3.49e-06	0.000104	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.48e-06	0.000104	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CD—ovarian cancer	3.42e-06	0.000102	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CG—ovarian cancer	3.37e-06	0.0001	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CD—ovarian cancer	3.36e-06	0.0001	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—FASN—ovarian cancer	3.34e-06	9.97e-05	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—PIK3CA—ovarian cancer	3.33e-06	9.95e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PTEN—ovarian cancer	3.31e-06	9.89e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—KRAS—ovarian cancer	3.29e-06	9.83e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.29e-06	9.81e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—ABCB1—ovarian cancer	3.25e-06	9.69e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CD—ovarian cancer	3.23e-06	9.63e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CAV1—ovarian cancer	3.22e-06	9.61e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	3.2e-06	9.55e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—TYMS—ovarian cancer	3.19e-06	9.52e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.17e-06	9.48e-05	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—AKT1—ovarian cancer	3.13e-06	9.35e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CB—ovarian cancer	3.05e-06	9.09e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.04e-06	9.08e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CAV1—ovarian cancer	3.03e-06	9.06e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—PIK3CA—ovarian cancer	3.03e-06	9.03e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CAV1—ovarian cancer	3.01e-06	8.98e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CB—ovarian cancer	2.98e-06	8.91e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—ERBB2—ovarian cancer	2.97e-06	8.87e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CD—ovarian cancer	2.96e-06	8.83e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CG—ovarian cancer	2.93e-06	8.75e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MTOR—ovarian cancer	2.93e-06	8.75e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CB—ovarian cancer	2.93e-06	8.75e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.87e-06	8.58e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CXCL8—ovarian cancer	2.82e-06	8.41e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CB—ovarian cancer	2.81e-06	8.4e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—HRAS—ovarian cancer	2.8e-06	8.36e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	2.76e-06	8.25e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CDKN1B—ovarian cancer	2.75e-06	8.21e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CG—ovarian cancer	2.74e-06	8.18e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	2.74e-06	8.17e-05	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—AKT1—ovarian cancer	2.72e-06	8.13e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.7e-06	8.06e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CASP3—ovarian cancer	2.7e-06	8.05e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL2—ovarian cancer	2.69e-06	8.04e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—IL6—ovarian cancer	2.68e-06	8e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PTEN—ovarian cancer	2.63e-06	7.86e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CCND1—ovarian cancer	2.63e-06	7.84e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—AKT1—ovarian cancer	2.61e-06	7.8e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CTNNB1—ovarian cancer	2.6e-06	7.76e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CB—ovarian cancer	2.58e-06	7.7e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PTEN—ovarian cancer	2.58e-06	7.7e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CD—ovarian cancer	2.58e-06	7.69e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CAV1—ovarian cancer	2.57e-06	7.67e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MMP9—ovarian cancer	2.55e-06	7.61e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PTEN—ovarian cancer	2.53e-06	7.56e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PIK3CA—ovarian cancer	2.51e-06	7.5e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PIK3CA—ovarian cancer	2.51e-06	7.48e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.51e-06	7.48e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—AKT1—ovarian cancer	2.47e-06	7.38e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—TYMS—ovarian cancer	2.46e-06	7.35e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.46e-06	7.33e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PTEN—ovarian cancer	2.43e-06	7.26e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	2.43e-06	7.25e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.41e-06	7.19e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.34e-06	6.99e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CA—ovarian cancer	2.34e-06	6.98e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—VEGFA—ovarian cancer	2.29e-06	6.83e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—STAT3—ovarian cancer	2.27e-06	6.76e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NRAS—ovarian cancer	2.26e-06	6.75e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.25e-06	6.71e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—AKT1—ovarian cancer	2.24e-06	6.67e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PTEN—ovarian cancer	2.23e-06	6.65e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MAPK3—ovarian cancer	2.17e-06	6.46e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.12e-06	6.32e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MYC—ovarian cancer	2.11e-06	6.29e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.1e-06	6.27e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MAPK1—ovarian cancer	2.06e-06	6.15e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—EGFR—ovarian cancer	2.06e-06	6.15e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	2.06e-06	6.14e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—AKT1—ovarian cancer	2.05e-06	6.12e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—AKT1—ovarian cancer	2.05e-06	6.11e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CAV1—ovarian cancer	1.98e-06	5.92e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—KRAS—ovarian cancer	1.95e-06	5.81e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PTEN—ovarian cancer	1.94e-06	5.8e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—AKT1—ovarian cancer	1.91e-06	5.7e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CA—ovarian cancer	1.86e-06	5.54e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PTEN—ovarian cancer	1.83e-06	5.46e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CA—ovarian cancer	1.82e-06	5.43e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PTEN—ovarian cancer	1.81e-06	5.41e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.81e-06	5.39e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.79e-06	5.35e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CA—ovarian cancer	1.79e-06	5.34e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TP53—ovarian cancer	1.73e-06	5.16e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CA—ovarian cancer	1.71e-06	5.12e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HRAS—ovarian cancer	1.65e-06	4.94e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.59e-06	4.74e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL6—ovarian cancer	1.58e-06	4.72e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.57e-06	4.69e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PTEN—ovarian cancer	1.55e-06	4.63e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—AKT1—ovarian cancer	1.52e-06	4.53e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—AKT1—ovarian cancer	1.49e-06	4.44e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—AKT1—ovarian cancer	1.46e-06	4.36e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—AKT1—ovarian cancer	1.4e-06	4.18e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.38e-06	4.13e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.37e-06	4.09e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.29e-06	3.85e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—AKT1—ovarian cancer	1.28e-06	3.83e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.28e-06	3.82e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PTEN—ovarian cancer	1.2e-06	3.57e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—AKT1—ovarian cancer	1.12e-06	3.34e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.09e-06	3.26e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—AKT1—ovarian cancer	1.05e-06	3.15e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—AKT1—ovarian cancer	1.05e-06	3.12e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—AKT1—ovarian cancer	8.93e-07	2.67e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	8.44e-07	2.52e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—AKT1—ovarian cancer	6.89e-07	2.06e-05	CbGpPWpGaD
